Breaking News
FONT-SIZE Plus   Neg
Share SHARE

CVC Capital Partners, ValueAct Continue To Consider Options In Respect Of Misys

Funds advised by CVC Capital Partners Ltd. and ValueAct Capital Master Fund, L.P. noted the recent announcement by Vista of its recommended cash offer for Misys Plc (MSY.L, MUSJF.PK).

Misys had announced today that it agreed to be acquired by an investment vehicle owned by US-based private equity firm Vista Equity Partners for 350 pence per share, totaling about 1.3 billion pounds.

CVC and ValueAct continue to consider their options in respect of Misys, including a possible recommended joint cash offer for the company and urge Misys shareholders to take no action at this time.

However, there can be no certainty that an offer will be made by CVC and ValueAct, nor, if made, that a deal will result.

Click here to receive FREE breaking news email alerts for Misys plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.